Stock name 2-day closing price ⇒ previous day comparison.

Laser Tech <6920> 22785 -1150

The USA SOX index fell by nearly 3%.

PKSHA Technology <3993> 3370 -220

There is also a sense of exhaustion in the rise after the transition to the main board.

KOKUSAI ELECTRIC <6525> 3130 -135

During the risk-off, semiconductor manufacturing equipment is generally being sold.

Japan Micronics <6871> 3810 -295

Pushed by the sluggish trend in semiconductor-related.

*Sony Group Corp <6758> 2750.5 -83.5

Target stock price downgrades at Macquarie Securities and JP Morgan Securities.

*Change HD <3962> 1350 -100

Also, there is a backlash in the recent sharp rise as a stock expected for policy.

*ZOZO <3092> 4974 -216

There is a dominant trend of profit-taking sales in the high range.

*Nexon <3659> 2757 -118

Tokai Tokyo Securities lowered its target stock price the day before.

*Ikuyo <7273> 3035 +256

Expectations are rising for joint ventures with major Chinese construction machinery manufacturers.

*Sailor Advertising <2156> 492 +80

Continuing to gain popularity as part of revitalizing regional areas.

*ETS Group <253A> 627 +27

On the day before the IPO, there was follow-up buying with a large positive line.

*Collec HD <6578> 280 -24

Especially disposing of credit buying positions without any specific materials etc.

*GeneXst <4179> 274 -7

Major beverage and food business holding company and

Starting a verification experiment using 'Discoveriez AI'. After the initial round of buying, it loses momentum.

*HeartSeed <219A> 1626 -17

In the domestic Phase 1/2 clinical trial (LAPiS trial) of iPS cell-derived myocardial spheres from other companies,

Review regarding the first administration in the high-dose group completed.

*GENDA <9166> 2745 -130

At the end of September, the number of domestic mini-loco (gaming corners without staff) locations

decreased by 60 from the previous month to 820. The downside is limited.

*Tsubota Lab <4890> 450 ±0

Rohto Pharmaceutical <4527> signs evaluation agreement for eye drops. Although there was buying ahead, a long bearish trend followed.

*Modalis <4883> 102 +3

The candidate drug for congenital muscular dystrophy type 1a received rare pediatric disease designation in the USA and gained popularity the previous day.

Today's market is dominated by sellers.

*Perseus <4882> 671 +19

The abstract of the presentation of the radioisotope-labeled antibody PPMX-T002 at the European Nuclear Medicine Association is now available for public release.

Reached the daily limit increase the previous day. Today, there is a mix of buying and selling.

*Sinbio Pharmaceutical <4582> 253 -5

Settled patent infringement lawsuit with Toawa Pharmaceuticals <4553> leading to an increase the day before. Today, selling pressure is dominant.

*One-Plus <4199> 918 -8

Expected operating profit for the fiscal year ending August 2024 is 2.4 times higher than the previous year, resulting in buying the day before. Today, selling pressure is dominant.

*Baby Calendar <7363> 1485 +56

Providing marketing support utilizing a physician network.

Subsidiarizing Medical Research.

*Integle <192A> 3665 +80

First quarter operating profit and loss was a deficit of 11.8 billion yen, significantly down from the previous day. Today, there is a strong preference for buying on the dips.